Fortress Biotech, Inc. (FBIO) financial statements (2021 and earlier)

Company profile

Business Address 2 GANSEVOORT STREET
NEW YORK, NY 10014
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13783150889870100
Cash and cash equivalents13766114889850100
Short-term investments 1836  20 
Receivables146105   
Inventory, net of allowances, customer advances and progress billings1100  
Inventory1100   
Prepaid expense  1    
Disposal group, including discontinued operation 13     
Other undisclosed current assets492216211
Total current assets:15611118311010070100
Noncurrent Assets
Operating lease, right-of-use asset21
Property, plant and equipment1212107000
Long-term investments and receivables11 1124 
Long-term investments11 1124 
Intangible assets, net (including goodwill)7134361 
Goodwill  1919   
Intangible assets, net (excluding goodwill)7115171  
Restricted cash and investments171617161515 
Other noncurrent assets1010000
Total noncurrent assets:7030636119191
TOTAL ASSETS:22614124617111989101
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:353436241055
Accounts payable    200
Accrued liabilities25161810944
Employee-related liabilities  1012 1 
Taxes payable      0
Interest and dividends payable110000 
Other undisclosed accounts payable and accrued liabilities91682   
Debt210132  6
Derivative instruments and hedges, liabilities01000  
Due to related parties7000   
Deferred revenue and credits11   
Other liabilities  00   
Other undisclosed current liabilities1101728 (1)(0)
Total current liabilities:4656675711411
Noncurrent Liabilities
Long-term debt and lease obligation10160432323147
Long-term debt, excluding current maturities7760432323147
Operating lease, liability24
Liabilities, other than long-term debt7555111
Deferred revenue and credits   0 
Other liabilities7555111
Other undisclosed noncurrent liabilities  104 (0) 
Total noncurrent liabilities:10866583124158
Total liabilities:15412112588341919
Stockholders' equity
Stockholders' equity attributable to parent2625338577181
Preferred stock000    
Common stock0000000
Common stock, value, subscriptions111   
Additional paid in capital462397364284247212203
Accumulated deficit(436)(396)(312)(245)(190)(142)(121)
Stockholders' equity attributable to noncontrolling interest4618684427  
Total stockholders' equity:732012183847181
TOTAL LIABILITIES AND EQUITY:22614124617111989101

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues3727188161  
Revenue, net188161  
Cost of revenue(18)(6)(4)    
Cost of goods and services sold(11)(6)(4)    
Gross profit:1821184161  
Operating expenses(129)(147)(289)(82)(51)(22)(36)
Other undisclosed operating income 64  10
Operating loss:(111)(120)(101)(66)(51)(21)(36)
Nonoperating income (expense)9(11)3(6)(3)11
Investment income, nonoperating3110011
Interest and debt expense(0)(0)(6)(4)(1)(1)(2)
Other undisclosed income from continuing operations before equity method investments, income taxes006    
Loss from continuing operations before income taxes:(102)(131)(98)(75)(55)(21)(37)
Income tax expense  (2)    
Loss from continuing operations:(102)(131)(100)(75)(55)(21)(37)
Loss from discontinued operations (11)     
Loss before gain (loss) on sale of properties:(102)(142)(100)(75)(55)(21)(37)
Other undisclosed net income   41  
Net loss:(102)(142)(100)(71)(54)(21)(37)
Net income attributable to noncontrolling interest625833165  
Other undisclosed net income attributable to parent     1 
Net loss available to common stockholders, diluted:(40)(84)(67)(55)(48)(20)(37)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(102)(142)(100)(71)(54)(21)(37)
Comprehensive loss:(102)(142)(100)(71)(54)(21)(37)
Comprehensive income, net of tax, attributable to noncontrolling interest625833165  
Comprehensive loss, net of tax, attributable to parent:(40)(84)(67)(55)(48)(21)(37)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: